Radionuclide Imaging-Guided Chemo-Radioisotope Synergistic Therapy Using a 131I-Labeled Polydopamine Multifunctional Nanocarrier
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 26 (5) , 1385-1393
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81571721, 81772010, 81227901, 81471716)
- Natural Science Basis Research Plan (2016JM8016)
This publication has 25 references indexed in Scilit:
- Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapyAdvanced Drug Delivery Reviews, 2012
- Understanding drug uptake and binding within targeted disease micro‐environments in patients: a new tool for translational medicineClinical and Translational Medicine, 2012
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cellsScientific Reports, 2012
- Theranostic Nanoparticles Engineered for Clinic and PharmaceuticsAccounts of Chemical Research, 2011
- The Role of Nanomaterials in Translational MedicineACS Nano, 2011
- Bioinspired Polymerization of Dopamine to Generate Melanin-Like Nanoparticles Having an Excellent Free-Radical-Scavenging PropertyBiomacromolecules, 2011
- Multi-functional nanocarriers to overcome tumor drug resistanceCancer Treatment Reviews, 2008
- Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)Journal of Clinical Oncology, 2008
- Therapeutic Nanoparticles for Drug Delivery in CancerClinical Cancer Research, 2008
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000